Gliomas Harboring IDH1 and/or IDH2 Mutations
Oncology·MeSH: Glioma
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| hmpl-306 | HUTCHMED (China) Ltd (HMDCF) |
Frequently asked questions
How many drugs are in development for Gliomas Harboring IDH1 and/or IDH2 Mutations?
BioSniper tracks 1 drug in development for Gliomas Harboring IDH1 and/or IDH2 Mutations across 1 company.
How many clinical trials target Gliomas Harboring IDH1 and/or IDH2 Mutations?
There are 1 clinical trial targeting Gliomas Harboring IDH1 and/or IDH2 Mutations tracked by BioSniper.
Deep-dive into Gliomas Harboring IDH1 and/or IDH2 Mutations
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis